Advisor Group Holdings, Inc. Axcella Health Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$0.22 - $0.46 $2 - $4	10 New	10 $0
Q2 2022 Aug 10, 2022	SELL	$1.41 - $2.77 $7,050 - $13,850	-5,000 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$1.58 - $2.82 $7,900 - $14,100	5,000 New	5,000 $13,000
Q3 2020 Nov 12, 2020	SELL	$4.12 - $5.91 $412 - $591	-100 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.94 - $7.7 $294 - $770	100 New	100 $1,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.